TC
TEVA icon

TownSquare Capital’s Teva Pharmaceuticals TEVA Stock Holding History

TownSquare Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,783
Closed -$658K – 1498
2025
Q1 		$658K Buy
42,783
+2,621
+7% +$46.8K 0.01% 1011
2024
Q4 		$885K Buy
40,162
+812
+2% +$14.8K 0.01% 808
2024
Q3 		$709K Buy
+39,350
New +$689K 0.01% 831

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

TownSquare Capital's TEVA Position: Q2 2025 in Review

TownSquare Capital sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 42,783 shares — an estimated $658K sold.

TownSquare Capital first reported a position in TEVA in Q3 2024 and held it in 3 quarters. The position peaked at $885K in Q4 2024. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • TownSquare Capital reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 42,783 Teva Pharmaceuticals shares in Q2 2025, an estimated $658K.
  • TownSquare Capital first reported a position in Teva Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • TownSquare Capital's Teva Pharmaceuticals position peaked at $885K in Q4 2024.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.